RadNet EBITDA 2010-2024 | RDNT

RadNet annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • RadNet EBITDA for the quarter ending September 30, 2024 was $0.086B, a 7.4% decline year-over-year.
  • RadNet EBITDA for the twelve months ending September 30, 2024 was $0.310B, a 5.56% increase year-over-year.
  • RadNet 2023 annual EBITDA was $0.295B, a 24.12% increase from 2022.
  • RadNet 2022 annual EBITDA was $0.237B, a 8.72% decline from 2021.
  • RadNet 2021 annual EBITDA was $0.26B, a 31.23% increase from 2020.
RadNet Annual EBITDA
(Millions of US $)
2023 $295
2022 $237
2021 $260
2020 $198
2019 $222
2018 $108
2017 $120
2016 $110
2015 $105
2014 $118
2013 $107
2012 $111
2011 $115
2010 $101
2009 $106
RadNet Quarterly EBITDA
(Millions of US $)
2024-09-30 $86
2024-06-30 $92
2024-03-31 $60
2023-12-31 $72
2023-09-30 $93
2023-06-30 $74
2023-03-31 $55
2022-12-31 $71
2022-09-30 $55
2022-06-30 $67
2022-03-31 $44
2021-12-31 $50
2021-09-30 $78
2021-06-30 $72
2021-03-31 $60
2020-12-31 $63
2020-09-30 $64
2020-06-30 $40
2020-03-31 $31
2019-12-31 $62
2019-09-30 $55
2019-06-30 $60
2019-03-31 $44
2018-12-31 $20
2018-09-30 $35
2018-06-30 $35
2018-03-31 $18
2017-12-31 $36
2017-09-30 $29
2017-06-30 $32
2017-03-31 $24
2016-12-31 $33
2016-09-30 $31
2016-06-30 $25
2016-03-31 $21
2015-12-31 $29
2015-09-30 $33
2015-06-30 $29
2015-03-31 $15
2014-12-31 $30
2014-09-30 $31
2014-06-30 $34
2014-03-31 $23
2013-12-31 $27
2013-09-30 $26
2013-06-30 $30
2013-03-31 $24
2012-12-31 $23
2012-09-30 $29
2012-06-30 $32
2012-03-31 $28
2011-12-31 $32
2011-09-30 $27
2011-06-30 $32
2011-03-31 $24
2010-12-31 $31
2010-09-30 $26
2010-06-30 $26
2010-03-31 $19
2009-12-31 $37
2009-09-30 $23
2009-06-30 $23
2009-03-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.284B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00